Nav: Home

'Screen and treat' approach to prevent type 2 diabetes unlikely to have major impact

January 04, 2017

"Screen and treat" policies to preventing type 2 diabetes are unlikely to have substantial impact on this growing epidemic, concludes a study published by The BMJ today.

The prevalence of type 2 diabetes is rising globally. In the UK, for example, about 3.2 million people have the condition and by 2025 it is predicted that this will increase to five million, at an estimated cost of £23.7bn ($30.2bn, €28.2bn) to the NHS.

There are two approaches to prevention: screen and treat, in which people are identified as "high risk" and offered individual intervention, and a population-wide approach, in which everyone is targeted via public health policies. The UK's National Diabetes Prevention Programme follows Australia and the United States in placing the emphasis on a screen and treat approach.

But this approach will be effective only if a test exists that correctly identifies those at high risk (sensitivity) while also excluding those at low risk (specificity); and an intervention exists that is acceptable to patients and clinicians.

So a team of researchers, led by Professor Trish Greenhalgh at the University of Oxford, assessed the diagnostic accuracy of screening tests for pre-diabetes (high risk of developing type 2 diabetes in the future) and effectiveness of interventions in preventing onset of type 2 diabetes in people with pre-diabetes.

They analysed the results of 49 studies of screening tests and 50 intervention trials.

Screening tests included fasting plasma glucose (higher than normal blood sugar levels after a period of fasting) and raised glycated haemoglobin or HbA1c (proportion of red blood cells with glucose attached, indicating blood glucose levels over the previous 2-3 months).

Interventions were lifestyle change or treatment with metformin (a drug that helps lower blood sugar levels).

They found that the diagnostic accuracy of tests used to detect pre-diabetes in screening programmes was low - fasting glucose is specific but not sensitive and HbA1c is neither sensitive nor specific - suggesting that large numbers of people will be unnecessarily treated or falsely reassured depending on the test used.

Lifestyle interventions lasting three to six years showed a 37% reduction in relative risk of type 2 diabetes, equating to 151 out of 1000 people developing diabetes compared with 239 of 1000 in the control group. This fell to 20% in follow up studies.

Use of metformin showed a relative risk reduction of 26% while participants were taking this drug, translating to 218 out of 1000 developing diabetes while taking metformin compared with 295 of 1000 not receiving it.

The authors warn that study quality was often low and results may have been affected by bias (problems in study design that can influence results).

They conclude that "screen and treat" policies will benefit some but not all people at high risk of developing diabetes, and they should be complemented by population-wide approaches for effective diabetes prevention.

In a linked editorial, Professor Norman Waugh from Warwick Medical School says adherence to lifestyle change across whole populations is the key to prevention of type 2 diabetes.

He points out that "pre-diabetes" is an unsatisfactory term because many people so labelled do not develop diabetes, and believes there is a balance to be struck between the medical model of screening and treating of individuals of individuals, and the public health model of changing behaviour in the whole population at risk.

He says public health measures targeted at the whole population at risk could include interventions to help weight control, such as changes to taxation of foodstuffs and interventions to make physical activity easier or safer.

However, he acknowledges that adherence to lifestyle advice remains poor, and concludes that preventing or delaying type 2 diabetes "requires effective measures to motivate the general population to protect their own health."
-end-
Research: Efficacy and effectiveness of screen and treat policies in prevention of type 2 diabetes: systematic review and meta-analysis of screening tests and interventions
http://www.bmj.com/cgi/doi/10.1136/bmj.i6538

Editorial: Screen and intervene to prevent diabetes?
http://www.bmj.com/cgi/doi/10.1136/bmj.i6800

About BMJ

BMJ is a healthcare knowledge provider that aims to advance healthcare worldwide by sharing knowledge and expertise to improve experiences, outcomes and value. For a full list of BMJ products and services, please visit bmj.com

BMJ

Related Diabetes Articles:

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.
Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.
Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).
Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.
Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.
Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.
Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).
Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.
People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.
Diabetes, but not diabetes drug, linked to poor pregnancy outcomes
New research indicates that pregnant women with pre-gestational diabetes who take metformin are at a higher risk for adverse pregnancy outcomes -- such as major birth defects and pregnancy loss -- than the general population, but their increased risk is not due to metformin but diabetes.
More Diabetes News and Diabetes Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: The Power Of Spaces
How do spaces shape the human experience? In what ways do our rooms, homes, and buildings give us meaning and purpose? This hour, TED speakers explore the power of the spaces we make and inhabit. Guests include architect Michael Murphy, musician David Byrne, artist Es Devlin, and architect Siamak Hariri.
Now Playing: Science for the People

#576 Science Communication in Creative Places
When you think of science communication, you might think of TED talks or museum talks or video talks, or... people giving lectures. It's a lot of people talking. But there's more to sci comm than that. This week host Bethany Brookshire talks to three people who have looked at science communication in places you might not expect it. We'll speak with Mauna Dasari, a graduate student at Notre Dame, about making mammals into a March Madness match. We'll talk with Sarah Garner, director of the Pathologists Assistant Program at Tulane University School of Medicine, who takes pathology instruction out of...
Now Playing: Radiolab

What If?
There's plenty of speculation about what Donald Trump might do in the wake of the election. Would he dispute the results if he loses? Would he simply refuse to leave office, or even try to use the military to maintain control? Last summer, Rosa Brooks got together a team of experts and political operatives from both sides of the aisle to ask a slightly different question. Rather than arguing about whether he'd do those things, they dug into what exactly would happen if he did. Part war game part choose your own adventure, Rosa's Transition Integrity Project doesn't give us any predictions, and it isn't a referendum on Trump. Instead, it's a deeply illuminating stress test on our laws, our institutions, and on the commitment to democracy written into the constitution. This episode was reported by Bethel Habte, with help from Tracie Hunte, and produced by Bethel Habte. Jeremy Bloom provided original music. Support Radiolab by becoming a member today at Radiolab.org/donate.     You can read The Transition Integrity Project's report here.